期刊文献+

增强型Trop2-CD40L病毒样颗粒疫苗的制备、纯化及活性研究 被引量:1

Expression,Purification and Activity Study on the Immune-Enhanced Trop2-CD40L Virus Like Particles
下载PDF
导出
摘要 目的 获得嵌合免疫增强佐剂CD40配体(CD40L)的Trop2-CD40L病毒样颗粒(VLPs)疫苗,为后续探究VLPs在肿瘤治疗中的免疫原性及免疫保护作用奠定基础。方法 通过重叠延伸PCR方法扩增以Trop2为靶点、嵌合免疫佐剂CD40L的Trop2-CD40L融合基因,构建杆状病毒表达载体pFastbacTM /Trop2-CD40L,并转化大肠埃希菌E.coli DH10bac,提取杆粒并经PCR鉴定成功命名为Trop2-CD40L Bacmid,后者转染Tn5昆虫细胞获得重组病毒Trop2-CD40L rBV,与Gag rBV共感染昆虫细胞制备重组病毒样颗粒,透析浓缩后蔗糖密度梯度离心纯化,Western Blot鉴定VLPs目的蛋白表达、电镜观察所制备VLPs形态,Cytokine ELISA方法检测Trop2-CD40L VLPs体外生物学活性。结果 成功扩增了Trop2-CD40L融合基因,通过杆状病毒表达系统、借助SIV Gag衣壳蛋白装配特点成功制备了增强型Trop2-CD40L 病毒样颗粒,与Trop2 VLPs比较具有更好的生物学活性,差异具有统计学意义(t=7.266,,P〈0.05)。结论 制备出具有一定生物学活性的增强型Trop2-CD40L病毒样颗粒,证实了CD40L作为免疫佐剂使用有免疫增强效应。 Objective To construct the immune-enhanced Virus like Particles (VLPs) based on Trop2-CD40L fusion protein, which laid the foundation for the subsequent induction of humoral and cellular immune response. Methods Firstly,amplified a Trop2-CD40L fusion gene by the method of over-lapping PCR, then cloned the fusion gene into pFastbacTM shuttle vector (named as pFastbac^TM/Trop2-CD40L). The constructed vector was then transformed into E. coli DH10Bac to build recombi- nant Trop2-CD40L Bacmid. The rBV/Trop2-CD40L was obtained by transfection TN5 insect cells with the Trop2-CD40L Bacmid,and finally,the Trop2-CD40L VLPs was prepared by co-infection TN5 cells with rBV/Gag and rBV/Trop2-CD40L in a MOI ratio of 1 : 10. After large scale preparation, VLPs was concentrated and purified bysucrose density gradient cen- trifugation. Then WB detection, electron microscope and Cytokine ELISA were performed to confirm the Trop2-CD40L VLPs production and it's in vitro biological activity(t= 7. 266 ,P〈0.05). Results Successfully amplified the Trop2-CD40L fusion gene by the method of overlapping PCR and expressed and purified Trop2-CD40L chimeric VLPs by using the Bac-to- Bac baculovirus expression system (SIV Gag was used as shell protein). Conclusion The Trop2-CD40L chimeric VLPs was successfully prepared, evidencing CD40L used as immune adjuvant immune activator,which established a fine theory and experiment basis for the further research.
出处 《现代检验医学杂志》 CAS 2016年第4期1-4,9,共5页 Journal of Modern Laboratory Medicine
基金 国家自然科学基金资助项目(81201775) 国家自然科学基金资助项目(81572974)
关键词 Trop2 CD40L 病毒样颗粒疫苗 trop2 CD40 ligand virus like particles vaccine
  • 相关文献

参考文献11

  • 1Ungaro F,Conte C, Quaglia F, et al. VLPs and parti- cle strategies for cancer vaccines[J]. Expert Rev Vac- cines,2013,12(10): 1173-1193.
  • 2Kapoor S. TROP2 expression and its evolving role in tumor pathogenesis in systemic tumors [J]. Tumour Bioi,2013,34(3) : 1967-1968.
  • 3Cubas R,Zhang S, Li M, et al. Chimeric Trop2 virus- like particles: a potential immunotherapeutic ap- proach against pancreatic cancer [J]. J Immunother, 2011,34(3) 5251-263.
  • 4Figgett WA, Vincent FB, Saulep-Easton D, et al. Ro- les of ligands from the TNF superfamily in B cell de- velopment,function,and regulation[J]. Semin Immu- no],2014,26(3) :191-202.
  • 5Chonan M, Saito R, Shoji T, et al. CD40/CD40L ex- pression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models[J]. Neuro Oncol,2015,17(11) : 1453-1462.
  • 6Vogel SZ, Schlickeiser S,Jurchott K, et al. TCAIM decreases T cell priming capacity of dendritic cells by inhibiting TLR-induced Ca2 + influx and IL-2 pro- duction[J]. J Immunol,2015,194(7) :3136-3146.
  • 7Ning S, Liang N, Liu B, et al. TROP2 expression and its correlation with tumor proliferation and angiogen- esis in human gliomas[J]. Neurol Sci, 2013,34 (10) : 1745-1750.
  • 8Yan D,Wei YQ,Guo HC,et al. The application of vi- rus-like particles as vaccines and biological vehicles [J]. Applied Microbiology and Biotechnology, 2015, 99(24) : 10415-10432.
  • 9Chroboczek J,Szurgot I, Szolajska E. Virus-like parti- cles as vaccine[J]. Acta Biochim Pol, 2014, 61 (3): 531-539.
  • 10Crosby CM,Weaver EA,Khare R, et al. A Novel co- don-optimized SIV gag-po| immunogen for gene- based vaccination[J]. Virol Rep,2015(5):47-55.

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部